drugset / Trial / NCT07228559
A Study of Avoralstat In Participants With Diabetic Macular Edema
NaSingle-groupOpen-labelTreatment
Summary
The goal of this study is to assess the safety and therapeutic potential of a single dose of avoralstat in adult participants with DME.
Timeline
- Start
- 2025-10-02
- Primary completion
- 2026-04-17
- Completion
- 2026-04-17
Outcome
Outcome not reported
Stopped (Business): “Strategic decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | avoralstat | Small molecule | — | Other |